HQH
abrdn Healthcare InvestorsMarquee-fund ownership over time
This quarter's activity
New positions opened
Positions exited
None.
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Millennium Management re-entered | Q3 2024(8Q snapshot) | 7Q | $0.00 | — | — |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at abrdn Healthcare Investors. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Jul 18, 2024 — the most recent Form 4 on file — not from today.
- Form 40001104659-24-080796Jul 18, 2024
- Form 40001104659-24-046547Apr 12, 2024
- Form 40001104659-24-002525Jan 9, 2024
- Form 40001104659-24-001270Jan 4, 2024
- Form 40001104659-24-000357Jan 2, 2024
- Form 40001104659-23-103574Sep 25, 2023
- Form 40001104659-23-102458Sep 20, 2023
- Form 40001104659-22-037466Mar 24, 2022
- Form 40001104659-22-008200Jan 27, 2022
- Form 40001104659-20-118219Oct 26, 2020
- Form 40001104659-20-116859Oct 21, 2020
- Form 40001104659-20-107790Sep 23, 2020
- Form 40001104659-20-065198May 22, 2020
- Form 40001104659-20-034865Mar 17, 2020
- Form 40001104659-18-074725Dec 26, 2018
Fundamentals
XBRL · abrdn Healthcare InvestorsNot enough XBRL history to plot. abrdn Healthcare Investorshasn't tagged revenue, net income, EPS, or operating cash flow in the SEC us-gaap taxonomy with at least two fiscal-year periods — typical for SPACs / trust vehicles, pre-revenue biotechs, recent IPOs, and foreign filers reporting under IFRS.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for abrdn Healthcare Investors — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- DEF 14AProxy statementApr 7, 2026
- DEF 14AProxy statementApr 14, 2025
- SC 13D/AFORM SC 13D/ANov 18, 2024
- SC 13D/AFORM SC 13D/AOct 22, 2024
- SC 13D/AFORM SC 13D/AMay 3, 2024
- DEF 14AProxy statementApr 22, 2024
- SC 13DFORM SC 13DMar 15, 2024
- SC 13G/AMS AMENDMENTFeb 12, 2024
- 8-KFORM 8-KSep 12, 2023
- DEF 14AProxy statementJul 10, 2023
- DEF 14AProxy statementApr 11, 2023
- SC 13G/AMS AMENDMENTFeb 10, 2023
- DEF 14AProxy statementApr 12, 2022
- SC 13G/AMS AMENDMENTFeb 11, 2022
- DEF 14AProxy statementApr 13, 2021
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Millennium Management | Q2 2026 | open | $0.00 | — | +0% |
| Millennium Management | Q3 2024 | Q1 2025 | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.